ストックスクリーナーアプリを入手
1.47
2.80%
0.04
アフターアワーズ：
1.43
-0.04
-2.72%
前日終値:
$1.43
開ける：
$1.448
24時間の取引高:
37,936
Relative Volume:
0.02
時価総額：
$7.85M
収益：
$3.25M
当期純損益:
$-8.34M
株価収益率:
-0.5708
EPS:
-2.5755
ネットキャッシュフロー:
$-7.71M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-5.77%
6か月 パフォーマンス:
+67.62%
1年 パフォーマンス:
-37.18%
1日の値動き範囲:
$1.44
$1.50
1週間の範囲:
$1.35
$1.50
52週間の値動き範囲:
$0.575
$2.4999
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
名前
Inmed Pharmaceuticals Inc
セクター
電話
(604) 669-7207
住所
1445-885 WEST GEORGIA ST., VANCOUVER
Compare INM vs TAK, TEVA, HLN, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
1.47 | 7.69M | 3.25M | -8.34M | -7.71M | -2.5755 |
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Inmed Pharmaceuticals Inc (INM) 最新ニュース
InMed Pharmaceuticals (INM) investor reports 4.2% beneficial stake in 137,634 shares - Stock Titan
Inmed Pharmaceuticals Stock Price Forecast. Should You Buy INM? - StockInvest.us
InMed Pharmaceuticals (INM) Rises 3.55% to $1.46 as Buyers Defend Key SupportMA Crossover - dars.gov.et
InMed Pharmaceuticals Inc (INM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
InMed Pharmaceuticals Inc (INM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
InMed Pharmaceuticals Inc (INM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
InMed Pharmaceuticals Inc (INM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
InMed Pharmaceuticals Inc (INM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
InMed Pharmaceuticals Inc (INM) Institutional Confidence - TradingKey
INM|InMed Pharmaceuticals Inc|Price:1.580|Chg%:-0.130 - TradingKey
TradingKey - TradingKey
INM|InMed Pharmaceuticals Inc|Price:1.670|Chg%:-0.040 - TradingKey
InMed Pharmaceuticals Inc. Revenue Breakdown – NASDAQ:INM - TradingView
InMed Pharmaceuticals Inc (INM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ADAR1 Capital Management, LLC Acquires Additional Shares in InMed Pharmaceuticals Inc - GuruFocus
Mentari merger financing reshapes InMed Pharmaceuticals’ future - The Globe and Mail
Mentari Therapeutics Raises $200 Million for Migraine Prevention Pipeline Ahead of InMed Merger - Minichart
InMed Pharmaceuticals (INM) plans Mentari merger with $490M financings - Stock Titan
InMed to Merge with Mentari as Mentari Secures $200M Pre-Closing Financing - TradingView
InMed Pharmaceuticals Merger Partner Raises $200 Million To Boost Migraine Pipeline - Benzinga
INM Stock Whipsaws As InMed Refines Mentari Merger Terms - StocksToTrade
InMed Pharmaceuticals (NASDAQ:INM) climbs after $200 million Mentari infusion strengthens merger funding calculations - TechStock²
INM Stock Jumps As Traders Digest Amended Mentari Merger - StocksToTrade
INM Stock Jumps As Amended Mentari Merger Takes Shape - timothysykes.com
Morning Market Movers: INM, INLF, SXTC, ADVB See Big Swings - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline - PR Newswire
InMed Pharmaceuticals Inc (NASDAQ: INM) Share Price, INM Stock News, INM Share Price & Updates - Kalkine
InMed (NASDAQ: INM) outlines Mentari merger structure and names new CEO - Stock Titan
InMed Pharmaceuticals (INM) Gains 1.3% as Stock Approaches Key Resistance LevelForce Index - dars.gov.et
ADAR1 Capital acquires 1,000 InMed common shares worth $1,555 - Bitget
InMed Pharmaceuticals (INM) holder buys 1,000 common shares via ADAR1 - Stock Titan
Vivo Opportunity reports USD 32,319 purchase of InMed common shares - Bitget
Vivo Opportunity funds add 20,546 InMed Pharmaceuticals (INM) shares - Stock Titan
InMed Pharmaceuticals(INM) Stock Options Chain | Quotes & News - Moomoo
InMed Pharmaceuticals Company Profile & Introduction - Moomoo
InMed Pharmaceuticals and Mentari Therapeutics Amend Merger Agreement and File Registration Statement for Migraine Therapy Deal 1 – Minichart - Minichart
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
InMed amends merger terms, advances Mentari transition - TipRanks
InMed Pharmaceuticals (Nasdaq: INM) refines structure of planned Mentari merger - Stock Titan
InMed Pharmaceuticals Updates Mentari Merger Terms, Adding PIPE Option and Confirming Tax Reorganization - TradingView
InMed Pharmaceuticals (NASDAQ: INM) clarifies Mentari merger structure and targets Q4 2026 closing - Stock Titan
Enterprise value to EBIT forward of InMed Pharmaceuticals Inc. – NASDAQ:INM - TradingView
InMed Pharmaceuticals Amends Deal With Mentari Therapeutics - Moomoo
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-NIMU, INM, OLN, and HUN - The Malaysian Reserve
InMed Pharmaceuticals (INM) Moves Forward with Merger Agreement Amendments - GuruFocus
InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 - TMX Newsfile
InMed Pharmaceuticals (INM) Stages 7% Advance: Testing Key Resistance LevelPut Dominated - DonanımHaber
InMed Pharmaceuticals และ Mentari Therapeutics ประกาศแก้ไขข้อตกลงการควบรวมกิจการ พร้อมยื่นแบบแสดงรายการข้อมูลการจดทะเบียน (Registration Statement) ตามแบบ Form S-4 - Moomoo
InMed Pharmaceuticals (INM) Slips 1.89% as Shares Test Key Support at $1.48Counter Trend Trade - dars.gov.et
INMInMed Pharmaceuticals Inc Forecast, Target Price - Finviz
Inmed Pharmaceuticals Inc (INM) 財務データ
収益
当期純利益
現金流量
EPS
0.79%
5.15%
大文字化:
|
ボリューム (24 時間):